Akito Tateyama, Akihito Kato, H. Miyaji, Erika Nishida, Y. Iwasaki, S. Fujii, K. Kawamoto, Kanako Shitomi, Tomokazu Furihata, Kayoko Mayumi, T. Sugaya
{"title":"Bone Induction by α-tricalcium Phosphate Microparticle Emulsion Containing Simvastatin","authors":"Akito Tateyama, Akihito Kato, H. Miyaji, Erika Nishida, Y. Iwasaki, S. Fujii, K. Kawamoto, Kanako Shitomi, Tomokazu Furihata, Kayoko Mayumi, T. Sugaya","doi":"10.11344/NANO.9.69","DOIUrl":null,"url":null,"abstract":"69 Introduction Significant bone loss due to periodontal disease, tumors or cysts requires the alveolar bone reconstruction. Block-shaped bone substitute materials have been used clinically to fill large bone defects [1, 2]; however, their low shapeability leads to low operability. To improve their operability, paste-like bone filling agents (bone pastes) are anticipated to be developed as bone graft materials. Calcium phosphate bone paste has been already applied for clinical use [3, 4]; however, bone paste is non-absorbable and Bone Induction by α-tricalcium Phosphate Microparticle Emulsion Containing Simvastatin","PeriodicalId":19070,"journal":{"name":"Nano Biomedicine","volume":"9 1","pages":"69-76"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11344/NANO.9.69","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano Biomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11344/NANO.9.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 1
Abstract
69 Introduction Significant bone loss due to periodontal disease, tumors or cysts requires the alveolar bone reconstruction. Block-shaped bone substitute materials have been used clinically to fill large bone defects [1, 2]; however, their low shapeability leads to low operability. To improve their operability, paste-like bone filling agents (bone pastes) are anticipated to be developed as bone graft materials. Calcium phosphate bone paste has been already applied for clinical use [3, 4]; however, bone paste is non-absorbable and Bone Induction by α-tricalcium Phosphate Microparticle Emulsion Containing Simvastatin